March 04, 2021
Americans in underserved communities face barriers to opioid use disorder treatment.
February 17, 2021
In addition to reducing the frequency of migraine days, galcanezumab may also potentially decrease disabling non-pain symptoms of migraine on days when migraine is present.
February 10, 2021
The relatively new biologic therapies for migraine demonstrated low immunogenicity rates and rare adverse events.
January 22, 2021
Patients reported more frequent and severe migraines, along with overuse of analgesics.
January 11, 2021
Tanvee Thakur, PhD, BPharm, recently completed a project focused on enhancing transparent opioid education.
January 08, 2021
Elizabeth Dragatsi, RPh, BCPS, worked on 2 projects integrating community pharmacists into contingency management and opioid education.
December 31, 2020
Here are some of the top-read FDA approvals covered by Drug Topics® from this year.
December 28, 2020
The Drug Topics® team rounded up some of our top-read articles from the last year.
December 23, 2020
You’ll be hard pressed to find a pharmacist as excited about change as Ashli Yoder, PharmD, the clinical services lead for Norland Avenue Pharmacy in Chambersburg, Pennsylvania.
December 21, 2020
Acetaminophen injection, 1000 mg/100 mL, is an FDA-approved generic to Ofirmev.
December 17, 2020
US prescription opioid use dropped 60% from its peak volume in 2011, according to a new report from the IQVIA Institute for Human Data Science.
December 08, 2020
Counsel patients on best practices for disposal of unused or expired pain medications.
November 27, 2020
The pharmaceutical company has submitted a New Drug Application for dihydroergotamine mesylate for fast and lasting whole migraine relief in adults with and without aura.
November 18, 2020
A study presented during PAINWeek 2020 Live Virtual Conference highlights the role of e-consultations in reducing opioid use.
November 11, 2020
Add value by optimizing medications, decreasing pill burden.
November 04, 2020
Often what parents reach for to relieve a child’s pain or fever, a new meta-analysis looks at the efficacy and safety of ibuprofen and acetaminophen.
October 22, 2020
A virtual session held during the NCPA 2020 Annual Convention discussed best practices for handling opioid prescriptions.
October 19, 2020
The agency warns that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby.
October 14, 2020
Oliceridine (Olinvyk; Trevena, Inc) is an intravenous opioid agonist indicated in adults for management of acute severe pain in a hospital or controlled clinical setting.
October 13, 2020
The rate of prescribing opioids among both oncologists and non-oncologists has dropped significantly in the past few years.
